Gender differences in the relationships among obesity, adiponectin and brachial artery distensibility in adolescents and young adults.
BACKGROUND
Obesity-related cardiovascular diseases (CVDs) are a major cause of cardiovascular (CV) mortality. Obesity-related reduction in vascular protective adipose-derived proteins, such as adiponectin (APN), has an important role.


METHODS
We compared brachial artery distensibility (BrachD) with APN, the level of adiposity and other CV risk factors (CVRFs) in 431 post-pubertal subjects (mean 17.9 years). Gender differences in average values were examined by t-tests. Correlations among BrachD, obesity and other CVRFs were examined. Regression analysis was performed to determine whether APN provided an independent contribution to BrachD, while controlling for obesity and other CVRFs.


RESULTS
Male subjects had lower BrachD (5.72+/-1.37 vs 6.45+/-1.60% change per mm Hg, P<0.0001) and lower APN (10.50+/-4.65 vs 13.20+/-6.53; all P<0.04) than female subjects. BrachD correlated with APN (r=0.25, P< 0.0001). Both BrachD and APN correlated with measures of body size, including height, weight and body mass index (BMI). Both correlated with higher systolic blood pressure, glucose, insulin and lower high-density lipoprotein cholesterol (all P<0.01). In multivariate analysis, APN, gender, APN*gender and BMI z-score predicted BrachD (r(2)=0.305). On the basis of gender difference, only BMI z-score was significant for male subjects (r(2)=0.080), whereas APN and BMI z-score contributed for female subjects (r(2)=0.242, all P<0.0001).


CONCLUSIONS
BrachD is independently influenced by obesity in both male and female subjects. In female subjects, APN exerts an additional independent effect even after adjusting for blood pressure (BP), lipid levels and insulin. Differences in the effect of the APN-adiposity relationship on obesity-related vascular disease may be one reason for gender differences in the development and progression of atherosclerosis.
Urbina
E M
EM
Division of Preventive Cardiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA. Elaine.Urbina@cchmc.org
Khoury
P
P
Martin
L J
LJ
D'Alessio
D
D
Dolan
L M
LM
D052242:Adiponectin / Q000097:blood*; D050154:Adiposity / Q000502:physiology*; D000293:Adolescent; D050197:Atherosclerosis / Q000097:blood / Q000503:physiopathology; D001794:Blood Pressure / Q000502:physiology*; D001823:Body Composition; D015992:Body Mass Index; D001916:Brachial Artery / Q000378:metabolism / Q000503:physiopathology*; D005260:Female; D006801:Humans; D008297:Male; D009765:Obesity / Q000097:blood / Q000150:complications / Q000503:physiopathology; D012307:Risk Factors; D012737:Sex Factors; D055815:Young Adult
D052242:Adiponectin
Circulation. 2004 Jun 1;109(21):2595-604
15173041
Diabetologia. 2004 May;47(5):816-20
15105989
J Clin Endocrinol Metab. 2004 Feb;89(2):765-9
14764794
J Clin Endocrinol Metab. 2005 Aug;90(8):4615-21
15886241
J Am Soc Hypertens. 2007 Jun;1(3):200-207
18431458
Circulation. 1999 Dec 21-28;100(25):2473-6
10604883
Circulation. 2005 Feb 15;111(6):747-53
15699257
Circulation. 2001 Feb 27;103(8):1057-63
11222466
Am J Cardiol. 1997 Aug 1;80(3):323-30
9264426
J Clin Endocrinol Metab. 2005 Jul;90(7):4170-6
15827100
Diabetes. 2002 Oct;51(10):2968-74
12351435
J Clin Endocrinol Metab. 2008 Jan;93(1):131-8
17925335
J Clin Endocrinol Metab. 2005 Jul;90(7):4255-9
15870125
Pediatrics. 2004 Aug;114(2 Suppl 4th Report):555-76
15286277
Am J Hypertens. 2005 Jun;18(6):767-71
15925733
J Clin Endocrinol Metab. 2003 Jul;88(7):3236-40
12843170
Diabetes Care. 2004 Feb;27(2):308-13
14747205
J Biol Chem. 2002 Oct 4;277(40):37487-91
12138120
J Clin Endocrinol Metab. 2003 Nov;88(11):5375-80
14602776
Curr Vasc Pharmacol. 2003 Jun;1(2):107-9
15320837
Int J Obes Relat Metab Disord. 2000 Jul;24(7):861-8
10918532
J Clin Endocrinol Metab. 2007 May;92(5):1857-62
17284625
J Clin Endocrinol Metab. 2006 Jan;91(1):332-5
16249291
Metabolism. 2006 May;55(5):587-92
16631433
J Clin Invest. 1998 Sep 15;102(6):1083-91
9739042
Can J Cardiol. 2006 Feb;22 Suppl B:12B-17B
16498507
Circulation. 2005 Sep 20;112(12):1789-97
16172286
Am J Hypertens. 2003 May;16(5 Pt 1):350-5
12745195
J Card Fail. 2004 Feb;10(1):36-42
14966773
Hypertension. 2000 Feb;35(2):637-42
10679510
Mol Endocrinol. 2007 Feb;21(2):388-400
17158222
Am J Cardiol. 2002 Apr 15;89(8):946-51
11950433
Am J Hypertens. 2005 Dec;18(12 Pt 1):1543-8
16364823
Echocardiography. 2006 Nov;23(10):835-42
17069601
J Hum Hypertens. 2002 Jul;16(7):509-16
12080436
J Pediatr. 2005 Jun;146(6):751-8
15973311
Blood Press Monit. 1998 Apr;3(2):121-124
10212341
Am J Hypertens. 2005 Jan;18(1):30-5
15691614
J Clin Endocrinol Metab. 2005 Aug;90(8):4792-6
15928248
Thromb Res. 2003 Jun 15;110(5-6):365-9
14592564
Atherosclerosis. 2004 Sep;176(1):157-64
15306189
Hypertension. 2008 Jan;51(1):8-14
17998473
Histochem Cell Biol. 2005 Jan;123(1):75-87
15616845
Perit Dial Int. 2005 Jul-Aug;25(4):357-61
16022092
J Clin Endocrinol Metab. 2001 Sep;86(9):4321-5
11549668
Diabetes Care. 2003 Aug;26(8):2383-8
12882866
Obes Res. 2003 Aug;11(8):1018-26
12917508
J Hypertens. 2005 Oct;23(10):1839-46
16148607
Am J Hypertens. 2003 Jan;16(1):76-9
12517688
Horm Metab Res. 2000 Feb;32(2):47-50
10741683
Diabetes Care. 2004 Mar;27(3):739-45
14988295
N Engl J Med. 2002 Mar 14;346(11):802-10
11893791
Mol Cell Biochem. 2007 Aug;302(1-2):43-9
17318406
Lancet. 2001 Oct 27;358(9291):1400-4
11705484
J Am Coll Cardiol. 2006 Sep 19;48(6):1155-62
16978998
J Clin Endocrinol Metab. 2002 Oct;87(10):4652-6
12364452
Clin Cardiol. 2002 Apr;25(4):167-72
12000074